Literature DB >> 6189901

Lymphocyte function in experimental African trypanosomiasis. VI. Parasite-specific immunosuppression.

W L Dempsey, J M Mansfield.   

Abstract

The ability of mice infected with African trypanosomes to produce antibodies to the surface antigen of the infecting trypanosome variant antigenic type upon primary and secondary exposure was examined. C57BL/10SnJ mice were infected initially with Trypanosoma rhodesiense clone LouTat 1.0. Surface antigen-specific antibody titers (IgM and IgG) to the infecting variant were measured throughout the course of infection; when the titers were sufficiently low, mice were reinfected with LouTat 1.0 trypanosomes and the antibody response was measured. Results demonstrate that mice in the early stage of infection exhibited transient suppression of antibody responses to LouTat 1.0 upon reexposure. In contrast, mice in the terminal phase of the disease were completely suppressed in their ability to mount a humoral response to LouTat 1.0. Trypanocidal chemotherapy of mice restored immunoresponsiveness in that treated mice responded with both IgM and IgG surface antigen-specific antibody to LouTat 1.0. The resulting antibody response, however, was more indicative of a primary humoral response to the parasites rather than a true secondary immune response.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6189901

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Trypanosomes expressing a mosaic variant surface glycoprotein coat escape early detection by the immune system.

Authors:  Melissa E Dubois; Karen P Demick; John M Mansfield
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

2.  Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease.

Authors:  Olga V Nikolskaia; Ana Paula C de A Lima; Yuri V Kim; John D Lonsdale-Eccles; Toshihide Fukuma; Julio Scharfstein; Dennis J Grab
Journal:  J Clin Invest       Date:  2006-09-21       Impact factor: 14.808

3.  Suppressor factor of T-cell activation and decreased interleukin 2 activity in experimental African trypanosomiasis.

Authors:  A Alcina; M Fresno
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

4.  Using T. brucei as a biological epitope-display platform to elicit specific antibody responses.

Authors:  Pete Stavropoulos; F Nina Papavasiliou
Journal:  J Immunol Methods       Date:  2010-08-26       Impact factor: 2.303

5.  Suppression by Trypanosoma brucei of anaphylaxis-mediated ion transport in the small intestine of rats.

Authors:  S S Gould; G A Castro
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

6.  Molecular identity and location of invariant antigens on Trypanosoma brucei rhodesiense defined with monoclonal antibodies reactive with sera from trypanosomiasis patients.

Authors:  D E Burgess; T Jerrells
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

7.  Trypanosoma brucei Co-opts NK Cells to Kill Splenic B2 B Cells.

Authors:  Deborah Frenkel; Fengqiu Zhang; Patrick Guirnalda; Carole Haynes; Viki Bockstal; Magdalena Radwanska; Stefan Magez; Samuel J Black
Journal:  PLoS Pathog       Date:  2016-07-12       Impact factor: 6.823

Review 8.  Interferon Gamma in African Trypanosome Infections: Friends or Foes?

Authors:  Hui Wu; Gongguan Liu; Meiqing Shi
Journal:  Front Immunol       Date:  2017-09-07       Impact factor: 7.561

9.  IL-27 Signaling Is Crucial for Survival of Mice Infected with African Trypanosomes via Preventing Lethal Effects of CD4+ T Cells and IFN-γ.

Authors:  Gongguan Liu; Jinjun Xu; Hui Wu; Donglei Sun; Xiquan Zhang; Xiaoping Zhu; Stefan Magez; Meiqing Shi
Journal:  PLoS Pathog       Date:  2015-07-29       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.